Several classes of compounds with potential antifolate activity are used in the treatment of cancer and rheumatoid arthritis (methotrexate, MTX), bacterial DHFR enzyme (trimethoprim, TMP), and the DHFR of P. falciparum (pyrimethamine, PYR). This evidence concerns the gene DHFR and cancer.